Evaluating the Effectiveness of NOACs and LMWH in Reducing Mortality in Critically Ill Patients With COVID‐19 Article Swipe
Rubens Costa Filho
,
Amarino Carvalho de Oliveira
,
Felipe Saddy
,
João Luiz Ferreira Costa
,
Marcela Santos Azevedo
,
Dominique Cerqueira
,
Víctor Hugo Amaral Gualberto
,
Maria Izabel de Holanda
,
Alda Maria Da‐Cruz
,
Marco Aurélio Pereira Horta
,
José Paulo Gagliardi Leite
,
Hugo C. Castro‐Faria‐Neto
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1002/jmv.70535
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1002/jmv.70535
Severe COVID‐19 is associated with increased prothrombotic and inflammatory responses, necessitating effective anticoagulation therapy. Novel oral anticoagulants (NOACs) are being explored as potential alternatives to low‐molecular‐weight heparin (LMWH). This retrospective observational cohort study compared the effectiveness and safety of NOACs and LMWH in reducing mortality among 76 critically ill, unvaccinated patients with confirmed SARS‐CoV‐2 infection. The cohort included 41 patients treated with LMWH and 35 with NOACs during their ICU stay. The primary outcomes was mortality, while secondary outcomes included deep vein thrombosis (DVT), bleeding episodes, and transfusion rates. Baseline characteristics, including demographic data and severity scores, were similar between the groups (mean age: LMWH, 74.5 ± 15.1 years [59% male]; NOAC, 71.6 ± 14.8 years [60% male]). Mortality was significantly higher in the LMWH group (51.21% [95% confidence interval (CI): 36.4–65.7]) compared to the NOAC group (20% [95% CI: 10.0–35.9]; p = 0.005), with standardized mortality ratios of 1.61 and 0.71, respectively ( p = 0.004). Elevated d ‐dimer levels were strongly associated with an increased risk of mortality. Deep vein thrombosis (DVT) occurred in 9.76% of patients in the LMWH group and 5.71% of those in the NOAC group ( p = 0.68). Bleeding and transfusion rates were comparable between the groups. The use of NOACs was associated with a significantly lower mortality rate compared to LMWH in critically ill COVID‐19 patients, reflecting an 81% reduction in the risk of death. These findings highlight the potential benefits of NOACs in the management of severe COVID‐19 and underscore the need for further research to optimize anticoagulation strategies and improve patient outcomes.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1002/jmv.70535
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.70535
- OA Status
- hybrid
- References
- 50
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4412857578
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4412857578Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1002/jmv.70535Digital Object Identifier
- Title
-
Evaluating the Effectiveness of NOACs and LMWH in Reducing Mortality in Critically Ill Patients With COVID‐19Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-08-01Full publication date if available
- Authors
-
Rubens Costa Filho, Amarino Carvalho de Oliveira, Felipe Saddy, João Luiz Ferreira Costa, Marcela Santos Azevedo, Dominique Cerqueira, Víctor Hugo Amaral Gualberto, Maria Izabel de Holanda, Alda Maria Da‐Cruz, Marco Aurélio Pereira Horta, José Paulo Gagliardi Leite, Hugo C. Castro‐Faria‐NetoList of authors in order
- Landing page
-
https://doi.org/10.1002/jmv.70535Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.70535Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.70535Direct OA link when available
- Concepts
-
Medicine, Low molecular weight heparin, Deep vein, Thrombosis, Internal medicine, Retrospective cohort study, Mortality rate, Confidence interval, Cohort, Cohort studyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
50Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4412857578 |
|---|---|
| doi | https://doi.org/10.1002/jmv.70535 |
| ids.doi | https://doi.org/10.1002/jmv.70535 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40751706 |
| ids.openalex | https://openalex.org/W4412857578 |
| fwci | 0.0 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D008297 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Male |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D005260 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Female |
| mesh[3].qualifier_ui | Q000627 |
| mesh[3].descriptor_ui | D006495 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | therapeutic use |
| mesh[3].descriptor_name | Heparin, Low-Molecular-Weight |
| mesh[4].qualifier_ui | Q000009 |
| mesh[4].descriptor_ui | D006495 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | adverse effects |
| mesh[4].descriptor_name | Heparin, Low-Molecular-Weight |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D000368 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Aged |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D012189 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Retrospective Studies |
| mesh[7].qualifier_ui | Q000401 |
| mesh[7].descriptor_ui | D016638 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | mortality |
| mesh[7].descriptor_name | Critical Illness |
| mesh[8].qualifier_ui | Q000627 |
| mesh[8].descriptor_ui | D000925 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | therapeutic use |
| mesh[8].descriptor_name | Anticoagulants |
| mesh[9].qualifier_ui | Q000009 |
| mesh[9].descriptor_ui | D000925 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | adverse effects |
| mesh[9].descriptor_name | Anticoagulants |
| mesh[10].qualifier_ui | Q000401 |
| mesh[10].descriptor_ui | D000086382 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | mortality |
| mesh[10].descriptor_name | COVID-19 |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D008875 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Middle Aged |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D000093485 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | COVID-19 Drug Treatment |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D000369 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Aged, 80 and over |
| mesh[14].qualifier_ui | Q000139 |
| mesh[14].descriptor_ui | D006470 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | chemically induced |
| mesh[14].descriptor_name | Hemorrhage |
| mesh[15].qualifier_ui | Q000188 |
| mesh[15].descriptor_ui | D020246 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | drug therapy |
| mesh[15].descriptor_name | Venous Thrombosis |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D016896 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Treatment Outcome |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D000086402 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | SARS-CoV-2 |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D000284 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Administration, Oral |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D006801 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Humans |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D008297 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Male |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D005260 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Female |
| mesh[22].qualifier_ui | Q000627 |
| mesh[22].descriptor_ui | D006495 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | therapeutic use |
| mesh[22].descriptor_name | Heparin, Low-Molecular-Weight |
| mesh[23].qualifier_ui | Q000009 |
| mesh[23].descriptor_ui | D006495 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | adverse effects |
| mesh[23].descriptor_name | Heparin, Low-Molecular-Weight |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D000368 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Aged |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D012189 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Retrospective Studies |
| mesh[26].qualifier_ui | Q000401 |
| mesh[26].descriptor_ui | D016638 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | mortality |
| mesh[26].descriptor_name | Critical Illness |
| mesh[27].qualifier_ui | Q000627 |
| mesh[27].descriptor_ui | D000925 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | therapeutic use |
| mesh[27].descriptor_name | Anticoagulants |
| mesh[28].qualifier_ui | Q000009 |
| mesh[28].descriptor_ui | D000925 |
| mesh[28].is_major_topic | True |
| mesh[28].qualifier_name | adverse effects |
| mesh[28].descriptor_name | Anticoagulants |
| mesh[29].qualifier_ui | Q000401 |
| mesh[29].descriptor_ui | D000086382 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | mortality |
| mesh[29].descriptor_name | COVID-19 |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D008875 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Middle Aged |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D000093485 |
| mesh[31].is_major_topic | True |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | COVID-19 Drug Treatment |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D000369 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Aged, 80 and over |
| mesh[33].qualifier_ui | Q000139 |
| mesh[33].descriptor_ui | D006470 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | chemically induced |
| mesh[33].descriptor_name | Hemorrhage |
| mesh[34].qualifier_ui | Q000188 |
| mesh[34].descriptor_ui | D020246 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | drug therapy |
| mesh[34].descriptor_name | Venous Thrombosis |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D016896 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Treatment Outcome |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D000086402 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | SARS-CoV-2 |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D000284 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Administration, Oral |
| type | article |
| title | Evaluating the Effectiveness of NOACs and LMWH in Reducing Mortality in Critically Ill Patients With COVID‐19 |
| biblio.issue | 8 |
| biblio.volume | 97 |
| biblio.last_page | e70535 |
| biblio.first_page | e70535 |
| topics[0].id | https://openalex.org/T10041 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | COVID-19 Clinical Research Studies |
| topics[1].id | https://openalex.org/T11368 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9993000030517578 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2728 |
| topics[1].subfield.display_name | Neurology |
| topics[1].display_name | Long-Term Effects of COVID-19 |
| topics[2].id | https://openalex.org/T10322 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9905999898910522 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2740 |
| topics[2].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[2].display_name | Respiratory Support and Mechanisms |
| is_xpac | False |
| apc_list.value | 4020 |
| apc_list.currency | USD |
| apc_list.value_usd | 4020 |
| apc_paid.value | 4020 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 4020 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.914425253868103 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2776884760 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6739580631256104 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q2750727 |
| concepts[1].display_name | Low molecular weight heparin |
| concepts[2].id | https://openalex.org/C2778959117 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6648603677749634 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q430892 |
| concepts[2].display_name | Deep vein |
| concepts[3].id | https://openalex.org/C2780868729 |
| concepts[3].level | 2 |
| concepts[3].score | 0.622215211391449 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q261327 |
| concepts[3].display_name | Thrombosis |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.5179151892662048 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C167135981 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5086489915847778 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q2146302 |
| concepts[5].display_name | Retrospective cohort study |
| concepts[6].id | https://openalex.org/C179755657 |
| concepts[6].level | 2 |
| concepts[6].score | 0.4985623359680176 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q58702 |
| concepts[6].display_name | Mortality rate |
| concepts[7].id | https://openalex.org/C44249647 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4720999598503113 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q208498 |
| concepts[7].display_name | Confidence interval |
| concepts[8].id | https://openalex.org/C72563966 |
| concepts[8].level | 2 |
| concepts[8].score | 0.4229835867881775 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1303415 |
| concepts[8].display_name | Cohort |
| concepts[9].id | https://openalex.org/C201903717 |
| concepts[9].level | 2 |
| concepts[9].score | 0.4163905680179596 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q1778788 |
| concepts[9].display_name | Cohort study |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.914425253868103 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/low-molecular-weight-heparin |
| keywords[1].score | 0.6739580631256104 |
| keywords[1].display_name | Low molecular weight heparin |
| keywords[2].id | https://openalex.org/keywords/deep-vein |
| keywords[2].score | 0.6648603677749634 |
| keywords[2].display_name | Deep vein |
| keywords[3].id | https://openalex.org/keywords/thrombosis |
| keywords[3].score | 0.622215211391449 |
| keywords[3].display_name | Thrombosis |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.5179151892662048 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/retrospective-cohort-study |
| keywords[5].score | 0.5086489915847778 |
| keywords[5].display_name | Retrospective cohort study |
| keywords[6].id | https://openalex.org/keywords/mortality-rate |
| keywords[6].score | 0.4985623359680176 |
| keywords[6].display_name | Mortality rate |
| keywords[7].id | https://openalex.org/keywords/confidence-interval |
| keywords[7].score | 0.4720999598503113 |
| keywords[7].display_name | Confidence interval |
| keywords[8].id | https://openalex.org/keywords/cohort |
| keywords[8].score | 0.4229835867881775 |
| keywords[8].display_name | Cohort |
| keywords[9].id | https://openalex.org/keywords/cohort-study |
| keywords[9].score | 0.4163905680179596 |
| keywords[9].display_name | Cohort study |
| language | en |
| locations[0].id | doi:10.1002/jmv.70535 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S49828768 |
| locations[0].source.issn | 0146-6615, 1096-9071 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0146-6615 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Journal of Medical Virology |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.70535 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Medical Virology |
| locations[0].landing_page_url | https://doi.org/10.1002/jmv.70535 |
| locations[1].id | pmid:40751706 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Journal of medical virology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40751706 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5011142198 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-9725-3762 |
| authorships[0].author.display_name | Rubens Costa Filho |
| authorships[0].countries | BR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210151502 |
| authorships[0].affiliations[0].raw_affiliation_string | Intensive Care Unit, Hospital Pró‐Cardíaco, Rio de Janeiro Rio de Janeiro RJ Brazil |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I40034438, https://openalex.org/I4210131693 |
| authorships[0].affiliations[1].raw_affiliation_string | Faculdade de Medicina, Universidade Estácio de Sá, IDOMED Rio de Janeiro RJ Brazil |
| authorships[0].affiliations[2].institution_ids | https://openalex.org/I52325 |
| authorships[0].affiliations[2].raw_affiliation_string | Laboratory of Immunopharmacology – IOC/FIOCRUZ Rio de Janeiro RJ Brazil |
| authorships[0].institutions[0].id | https://openalex.org/I4210131693 |
| authorships[0].institutions[0].ror | https://ror.org/02vej5573 |
| authorships[0].institutions[0].type | company |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210131693 |
| authorships[0].institutions[0].country_code | BR |
| authorships[0].institutions[0].display_name | Estácio (Brazil) |
| authorships[0].institutions[1].id | https://openalex.org/I52325 |
| authorships[0].institutions[1].ror | https://ror.org/04jhswv08 |
| authorships[0].institutions[1].type | facility |
| authorships[0].institutions[1].lineage | https://openalex.org/I52325 |
| authorships[0].institutions[1].country_code | BR |
| authorships[0].institutions[1].display_name | Fundação Oswaldo Cruz |
| authorships[0].institutions[2].id | https://openalex.org/I4210151502 |
| authorships[0].institutions[2].ror | https://ror.org/04qma4821 |
| authorships[0].institutions[2].type | healthcare |
| authorships[0].institutions[2].lineage | https://openalex.org/I4210151502 |
| authorships[0].institutions[2].country_code | BR |
| authorships[0].institutions[2].display_name | Hospital Pró-Cardíaco |
| authorships[0].institutions[3].id | https://openalex.org/I40034438 |
| authorships[0].institutions[3].ror | https://ror.org/0198v2949 |
| authorships[0].institutions[3].type | education |
| authorships[0].institutions[3].lineage | https://openalex.org/I40034438 |
| authorships[0].institutions[3].country_code | BR |
| authorships[0].institutions[3].display_name | Universidade do Estado do Rio de Janeiro |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Rubens Carmo Costa‐Filho |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Faculdade de Medicina, Universidade Estácio de Sá, IDOMED Rio de Janeiro RJ Brazil, Intensive Care Unit, Hospital Pró‐Cardíaco, Rio de Janeiro Rio de Janeiro RJ Brazil, Laboratory of Immunopharmacology – IOC/FIOCRUZ Rio de Janeiro RJ Brazil |
| authorships[1].author.id | https://openalex.org/A5111306402 |
| authorships[1].author.orcid | https://orcid.org/0009-0008-8430-6993 |
| authorships[1].author.display_name | Amarino Carvalho de Oliveira |
| authorships[1].countries | BR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210151502 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Radiology Hospital Pró‐Cardíaco Rio de Janeiro RJ Brazil |
| authorships[1].institutions[0].id | https://openalex.org/I4210151502 |
| authorships[1].institutions[0].ror | https://ror.org/04qma4821 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210151502 |
| authorships[1].institutions[0].country_code | BR |
| authorships[1].institutions[0].display_name | Hospital Pró-Cardíaco |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Amarino Oliveira |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Radiology Hospital Pró‐Cardíaco Rio de Janeiro RJ Brazil |
| authorships[2].author.id | https://openalex.org/A5005401027 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-0806-3204 |
| authorships[2].author.display_name | Felipe Saddy |
| authorships[2].countries | BR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210151502 |
| authorships[2].affiliations[0].raw_affiliation_string | Intensive Care Unit, Hospital Pró‐Cardíaco, Rio de Janeiro Rio de Janeiro RJ Brazil |
| authorships[2].institutions[0].id | https://openalex.org/I4210151502 |
| authorships[2].institutions[0].ror | https://ror.org/04qma4821 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210151502 |
| authorships[2].institutions[0].country_code | BR |
| authorships[2].institutions[0].display_name | Hospital Pró-Cardíaco |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Felipe Saddy |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Intensive Care Unit, Hospital Pró‐Cardíaco, Rio de Janeiro Rio de Janeiro RJ Brazil |
| authorships[3].author.id | https://openalex.org/A5071277500 |
| authorships[3].author.orcid | https://orcid.org/0009-0002-9672-9199 |
| authorships[3].author.display_name | João Luiz Ferreira Costa |
| authorships[3].countries | BR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210151502 |
| authorships[3].affiliations[0].raw_affiliation_string | Nephrology Department Hospital Pró‐Cardíaco Rio de Janeiro RJ Brazil |
| authorships[3].institutions[0].id | https://openalex.org/I4210151502 |
| authorships[3].institutions[0].ror | https://ror.org/04qma4821 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210151502 |
| authorships[3].institutions[0].country_code | BR |
| authorships[3].institutions[0].display_name | Hospital Pró-Cardíaco |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | João Luiz Ferreira Costa |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Nephrology Department Hospital Pró‐Cardíaco Rio de Janeiro RJ Brazil |
| authorships[4].author.id | https://openalex.org/A5113355373 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-7652-0817 |
| authorships[4].author.display_name | Marcela Santos Azevedo |
| authorships[4].countries | BR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I40034438, https://openalex.org/I4210131693 |
| authorships[4].affiliations[0].raw_affiliation_string | Faculdade de Medicina, Universidade Estácio de Sá, IDOMED Rio de Janeiro RJ Brazil |
| authorships[4].institutions[0].id | https://openalex.org/I4210131693 |
| authorships[4].institutions[0].ror | https://ror.org/02vej5573 |
| authorships[4].institutions[0].type | company |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210131693 |
| authorships[4].institutions[0].country_code | BR |
| authorships[4].institutions[0].display_name | Estácio (Brazil) |
| authorships[4].institutions[1].id | https://openalex.org/I40034438 |
| authorships[4].institutions[1].ror | https://ror.org/0198v2949 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I40034438 |
| authorships[4].institutions[1].country_code | BR |
| authorships[4].institutions[1].display_name | Universidade do Estado do Rio de Janeiro |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Marcela Santos Azevedo |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Faculdade de Medicina, Universidade Estácio de Sá, IDOMED Rio de Janeiro RJ Brazil |
| authorships[5].author.id | https://openalex.org/A5088961602 |
| authorships[5].author.orcid | https://orcid.org/0009-0007-5862-5256 |
| authorships[5].author.display_name | Dominique Cerqueira |
| authorships[5].countries | BR |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I40034438, https://openalex.org/I4210131693 |
| authorships[5].affiliations[0].raw_affiliation_string | Faculdade de Medicina, Universidade Estácio de Sá, IDOMED Rio de Janeiro RJ Brazil |
| authorships[5].institutions[0].id | https://openalex.org/I4210131693 |
| authorships[5].institutions[0].ror | https://ror.org/02vej5573 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210131693 |
| authorships[5].institutions[0].country_code | BR |
| authorships[5].institutions[0].display_name | Estácio (Brazil) |
| authorships[5].institutions[1].id | https://openalex.org/I40034438 |
| authorships[5].institutions[1].ror | https://ror.org/0198v2949 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I40034438 |
| authorships[5].institutions[1].country_code | BR |
| authorships[5].institutions[1].display_name | Universidade do Estado do Rio de Janeiro |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Débora Fragoso Cerqueira |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Faculdade de Medicina, Universidade Estácio de Sá, IDOMED Rio de Janeiro RJ Brazil |
| authorships[6].author.id | https://openalex.org/A5087552701 |
| authorships[6].author.orcid | https://orcid.org/0009-0007-2788-5223 |
| authorships[6].author.display_name | Víctor Hugo Amaral Gualberto |
| authorships[6].countries | BR |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I40034438, https://openalex.org/I4210131693 |
| authorships[6].affiliations[0].raw_affiliation_string | Faculdade de Medicina, Universidade Estácio de Sá, IDOMED Rio de Janeiro RJ Brazil |
| authorships[6].institutions[0].id | https://openalex.org/I4210131693 |
| authorships[6].institutions[0].ror | https://ror.org/02vej5573 |
| authorships[6].institutions[0].type | company |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210131693 |
| authorships[6].institutions[0].country_code | BR |
| authorships[6].institutions[0].display_name | Estácio (Brazil) |
| authorships[6].institutions[1].id | https://openalex.org/I40034438 |
| authorships[6].institutions[1].ror | https://ror.org/0198v2949 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I40034438 |
| authorships[6].institutions[1].country_code | BR |
| authorships[6].institutions[1].display_name | Universidade do Estado do Rio de Janeiro |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Víctor Hugo Amaral Gualberto |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Faculdade de Medicina, Universidade Estácio de Sá, IDOMED Rio de Janeiro RJ Brazil |
| authorships[7].author.id | https://openalex.org/A5082822383 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-3758-4946 |
| authorships[7].author.display_name | Maria Izabel de Holanda |
| authorships[7].countries | BR |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210151502 |
| authorships[7].affiliations[0].raw_affiliation_string | Nephrology Department Hospital Pró‐Cardíaco Rio de Janeiro RJ Brazil |
| authorships[7].institutions[0].id | https://openalex.org/I4210151502 |
| authorships[7].institutions[0].ror | https://ror.org/04qma4821 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210151502 |
| authorships[7].institutions[0].country_code | BR |
| authorships[7].institutions[0].display_name | Hospital Pró-Cardíaco |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Maria Izabel Neves de Holanda Barbosa |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Nephrology Department Hospital Pró‐Cardíaco Rio de Janeiro RJ Brazil |
| authorships[8].author.id | https://openalex.org/A5011876786 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-7455-2447 |
| authorships[8].author.display_name | Alda Maria Da‐Cruz |
| authorships[8].countries | BR |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I52325 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Parasitology/DMIP, Interdisciplinary Laboratory of Medical Research, IOC/FIOCRUZ, Faculty of Medical Sciences, UERJ, Rio de Janeiro, RJ, Brazil |
| authorships[8].institutions[0].id | https://openalex.org/I52325 |
| authorships[8].institutions[0].ror | https://ror.org/04jhswv08 |
| authorships[8].institutions[0].type | facility |
| authorships[8].institutions[0].lineage | https://openalex.org/I52325 |
| authorships[8].institutions[0].country_code | BR |
| authorships[8].institutions[0].display_name | Fundação Oswaldo Cruz |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Alda Maria Da‐Cruz |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Parasitology/DMIP, Interdisciplinary Laboratory of Medical Research, IOC/FIOCRUZ, Faculty of Medical Sciences, UERJ, Rio de Janeiro, RJ, Brazil |
| authorships[9].author.id | https://openalex.org/A5007034940 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-4117-5379 |
| authorships[9].author.display_name | Marco Aurélio Pereira Horta |
| authorships[9].countries | BR |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I52325 |
| authorships[9].affiliations[0].raw_affiliation_string | Laboratory of Hantavirus and Rickettsial Disease, IOC/FIOCRUZ, Rio de Janeiro, RJ, Brazil |
| authorships[9].institutions[0].id | https://openalex.org/I52325 |
| authorships[9].institutions[0].ror | https://ror.org/04jhswv08 |
| authorships[9].institutions[0].type | facility |
| authorships[9].institutions[0].lineage | https://openalex.org/I52325 |
| authorships[9].institutions[0].country_code | BR |
| authorships[9].institutions[0].display_name | Fundação Oswaldo Cruz |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Marco Aurélio Horta |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Laboratory of Hantavirus and Rickettsial Disease, IOC/FIOCRUZ, Rio de Janeiro, RJ, Brazil |
| authorships[10].author.id | https://openalex.org/A5103391162 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-8663-3527 |
| authorships[10].author.display_name | José Paulo Gagliardi Leite |
| authorships[10].countries | BR |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I52325 |
| authorships[10].affiliations[0].raw_affiliation_string | Laboratory of Comparative and Environmental Virology - IOC/FIOCRUZ, Rio de Janeiro, RJ, Brazil |
| authorships[10].institutions[0].id | https://openalex.org/I52325 |
| authorships[10].institutions[0].ror | https://ror.org/04jhswv08 |
| authorships[10].institutions[0].type | facility |
| authorships[10].institutions[0].lineage | https://openalex.org/I52325 |
| authorships[10].institutions[0].country_code | BR |
| authorships[10].institutions[0].display_name | Fundação Oswaldo Cruz |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | José Paulo Gagliardi Leite |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Laboratory of Comparative and Environmental Virology - IOC/FIOCRUZ, Rio de Janeiro, RJ, Brazil |
| authorships[11].author.id | https://openalex.org/A5053914254 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-0763-3578 |
| authorships[11].author.display_name | Hugo C. Castro‐Faria‐Neto |
| authorships[11].countries | BR |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I52325 |
| authorships[11].affiliations[0].raw_affiliation_string | Laboratory of Immunopharmacology – IOC/FIOCRUZ Rio de Janeiro RJ Brazil |
| authorships[11].affiliations[1].institution_ids | https://openalex.org/I40034438, https://openalex.org/I4210131693 |
| authorships[11].affiliations[1].raw_affiliation_string | Faculdade de Medicina, Universidade Estácio de Sá, IDOMED Rio de Janeiro RJ Brazil |
| authorships[11].institutions[0].id | https://openalex.org/I4210131693 |
| authorships[11].institutions[0].ror | https://ror.org/02vej5573 |
| authorships[11].institutions[0].type | company |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210131693 |
| authorships[11].institutions[0].country_code | BR |
| authorships[11].institutions[0].display_name | Estácio (Brazil) |
| authorships[11].institutions[1].id | https://openalex.org/I52325 |
| authorships[11].institutions[1].ror | https://ror.org/04jhswv08 |
| authorships[11].institutions[1].type | facility |
| authorships[11].institutions[1].lineage | https://openalex.org/I52325 |
| authorships[11].institutions[1].country_code | BR |
| authorships[11].institutions[1].display_name | Fundação Oswaldo Cruz |
| authorships[11].institutions[2].id | https://openalex.org/I40034438 |
| authorships[11].institutions[2].ror | https://ror.org/0198v2949 |
| authorships[11].institutions[2].type | education |
| authorships[11].institutions[2].lineage | https://openalex.org/I40034438 |
| authorships[11].institutions[2].country_code | BR |
| authorships[11].institutions[2].display_name | Universidade do Estado do Rio de Janeiro |
| authorships[11].author_position | last |
| authorships[11].raw_author_name | Hugo Castro‐Faria‐Neto |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Faculdade de Medicina, Universidade Estácio de Sá, IDOMED Rio de Janeiro RJ Brazil, Laboratory of Immunopharmacology – IOC/FIOCRUZ Rio de Janeiro RJ Brazil |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.70535 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Evaluating the Effectiveness of NOACs and LMWH in Reducing Mortality in Critically Ill Patients With COVID‐19 |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10041 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | COVID-19 Clinical Research Studies |
| related_works | https://openalex.org/W2083469408, https://openalex.org/W2076023803, https://openalex.org/W4388598541, https://openalex.org/W1998982063, https://openalex.org/W2001030107, https://openalex.org/W2416657662, https://openalex.org/W2938840962, https://openalex.org/W2034648015, https://openalex.org/W3149604253, https://openalex.org/W2002145739 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1002/jmv.70535 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S49828768 |
| best_oa_location.source.issn | 0146-6615, 1096-9071 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0146-6615 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Journal of Medical Virology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.70535 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of Medical Virology |
| best_oa_location.landing_page_url | https://doi.org/10.1002/jmv.70535 |
| primary_location.id | doi:10.1002/jmv.70535 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S49828768 |
| primary_location.source.issn | 0146-6615, 1096-9071 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0146-6615 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Journal of Medical Virology |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.70535 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Medical Virology |
| primary_location.landing_page_url | https://doi.org/10.1002/jmv.70535 |
| publication_date | 2025-08-01 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W3081306216, https://openalex.org/W3107596380, https://openalex.org/W4306318945, https://openalex.org/W6845980328, https://openalex.org/W3159275835, https://openalex.org/W4386501517, https://openalex.org/W3028989873, https://openalex.org/W3030113472, https://openalex.org/W3018952104, https://openalex.org/W4401113156, https://openalex.org/W4384154127, https://openalex.org/W4391692592, https://openalex.org/W3103969873, https://openalex.org/W3107353878, https://openalex.org/W4392104875, https://openalex.org/W4388115217, https://openalex.org/W2469676206, https://openalex.org/W4210305383, https://openalex.org/W4212795959, https://openalex.org/W3006882119, https://openalex.org/W2760564351, https://openalex.org/W3159188075, https://openalex.org/W4289646848, https://openalex.org/W4383426429, https://openalex.org/W4367833821, https://openalex.org/W3092819537, https://openalex.org/W4383218654, https://openalex.org/W3202637221, https://openalex.org/W4392919018, https://openalex.org/W4293367208, https://openalex.org/W3042270788, https://openalex.org/W6943855018, https://openalex.org/W4283744395, https://openalex.org/W3189793200, https://openalex.org/W3016641765, https://openalex.org/W3024268458, https://openalex.org/W3181132489, https://openalex.org/W4283573930, https://openalex.org/W3080389823, https://openalex.org/W3128604271, https://openalex.org/W2096054719, https://openalex.org/W2043788794, https://openalex.org/W4399117970, https://openalex.org/W4205281901, https://openalex.org/W3202229605, https://openalex.org/W2599933528, https://openalex.org/W4225133070, https://openalex.org/W6810650206, https://openalex.org/W3097325954, https://openalex.org/W3164173705 |
| referenced_works_count | 50 |
| abstract_inverted_index.( | 154, 192 |
| abstract_inverted_index.= | 143, 156, 194 |
| abstract_inverted_index.a | 212 |
| abstract_inverted_index.d | 159 |
| abstract_inverted_index.p | 142, 155, 193 |
| abstract_inverted_index.35 | 65 |
| abstract_inverted_index.41 | 59 |
| abstract_inverted_index.76 | 47 |
| abstract_inverted_index.an | 166, 226 |
| abstract_inverted_index.as | 22 |
| abstract_inverted_index.in | 43, 123, 176, 180, 188, 220, 229, 242 |
| abstract_inverted_index.is | 3 |
| abstract_inverted_index.of | 39, 149, 169, 178, 186, 207, 232, 240, 245 |
| abstract_inverted_index.to | 25, 134, 218, 255 |
| abstract_inverted_index.± | 107, 114 |
| abstract_inverted_index.81% | 227 |
| abstract_inverted_index.CI: | 140 |
| abstract_inverted_index.ICU | 70 |
| abstract_inverted_index.The | 56, 72, 205 |
| abstract_inverted_index.and | 8, 37, 41, 64, 87, 95, 151, 184, 197, 248, 259 |
| abstract_inverted_index.are | 19 |
| abstract_inverted_index.for | 252 |
| abstract_inverted_index.ill | 222 |
| abstract_inverted_index.the | 35, 101, 124, 135, 181, 189, 203, 230, 237, 243, 250 |
| abstract_inverted_index.use | 206 |
| abstract_inverted_index.was | 75, 120, 209 |
| abstract_inverted_index.(20% | 138 |
| abstract_inverted_index.1.61 | 150 |
| abstract_inverted_index.14.8 | 115 |
| abstract_inverted_index.15.1 | 108 |
| abstract_inverted_index.71.6 | 113 |
| abstract_inverted_index.74.5 | 106 |
| abstract_inverted_index.Deep | 171 |
| abstract_inverted_index.LMWH | 42, 63, 125, 182, 219 |
| abstract_inverted_index.NOAC | 136, 190 |
| abstract_inverted_index.This | 29 |
| abstract_inverted_index.[59% | 110 |
| abstract_inverted_index.[60% | 117 |
| abstract_inverted_index.[95% | 128, 139 |
| abstract_inverted_index.age: | 104 |
| abstract_inverted_index.data | 94 |
| abstract_inverted_index.deep | 81 |
| abstract_inverted_index.ill, | 49 |
| abstract_inverted_index.need | 251 |
| abstract_inverted_index.oral | 16 |
| abstract_inverted_index.rate | 216 |
| abstract_inverted_index.risk | 168, 231 |
| abstract_inverted_index.vein | 82, 172 |
| abstract_inverted_index.were | 98, 162, 200 |
| abstract_inverted_index.with | 5, 52, 62, 66, 145, 165, 211 |
| abstract_inverted_index.(CI): | 131 |
| abstract_inverted_index.(DVT) | 174 |
| abstract_inverted_index.(mean | 103 |
| abstract_inverted_index.0.71, | 152 |
| abstract_inverted_index.5.71% | 185 |
| abstract_inverted_index.9.76% | 177 |
| abstract_inverted_index.LMWH, | 105 |
| abstract_inverted_index.NOAC, | 112 |
| abstract_inverted_index.NOACs | 40, 67, 208, 241 |
| abstract_inverted_index.Novel | 15 |
| abstract_inverted_index.These | 234 |
| abstract_inverted_index.among | 46 |
| abstract_inverted_index.being | 20 |
| abstract_inverted_index.group | 126, 137, 183, 191 |
| abstract_inverted_index.lower | 214 |
| abstract_inverted_index.rates | 199 |
| abstract_inverted_index.stay. | 71 |
| abstract_inverted_index.study | 33 |
| abstract_inverted_index.their | 69 |
| abstract_inverted_index.those | 187 |
| abstract_inverted_index.while | 77 |
| abstract_inverted_index.years | 109, 116 |
| abstract_inverted_index.(DVT), | 84 |
| abstract_inverted_index.0.68). | 195 |
| abstract_inverted_index.Severe | 1 |
| abstract_inverted_index.cohort | 32, 57 |
| abstract_inverted_index.death. | 233 |
| abstract_inverted_index.during | 68 |
| abstract_inverted_index.groups | 102 |
| abstract_inverted_index.higher | 122 |
| abstract_inverted_index.levels | 161 |
| abstract_inverted_index.male]; | 111 |
| abstract_inverted_index.rates. | 89 |
| abstract_inverted_index.ratios | 148 |
| abstract_inverted_index.safety | 38 |
| abstract_inverted_index.severe | 246 |
| abstract_inverted_index.(51.21% | 127 |
| abstract_inverted_index.(LMWH). | 28 |
| abstract_inverted_index.(NOACs) | 18 |
| abstract_inverted_index.0.004). | 157 |
| abstract_inverted_index.0.005), | 144 |
| abstract_inverted_index.between | 100, 202 |
| abstract_inverted_index.further | 253 |
| abstract_inverted_index.groups. | 204 |
| abstract_inverted_index.heparin | 27 |
| abstract_inverted_index.improve | 260 |
| abstract_inverted_index.male]). | 118 |
| abstract_inverted_index.patient | 261 |
| abstract_inverted_index.primary | 73 |
| abstract_inverted_index.scores, | 97 |
| abstract_inverted_index.similar | 99 |
| abstract_inverted_index.treated | 61 |
| abstract_inverted_index.ABSTRACT | 0 |
| abstract_inverted_index.Baseline | 90 |
| abstract_inverted_index.Bleeding | 196 |
| abstract_inverted_index.Elevated | 158 |
| abstract_inverted_index.benefits | 239 |
| abstract_inverted_index.bleeding | 85 |
| abstract_inverted_index.compared | 34, 133, 217 |
| abstract_inverted_index.explored | 21 |
| abstract_inverted_index.findings | 235 |
| abstract_inverted_index.included | 58, 80 |
| abstract_inverted_index.interval | 130 |
| abstract_inverted_index.occurred | 175 |
| abstract_inverted_index.optimize | 256 |
| abstract_inverted_index.outcomes | 74, 79 |
| abstract_inverted_index.patients | 51, 60, 179 |
| abstract_inverted_index.reducing | 44 |
| abstract_inverted_index.research | 254 |
| abstract_inverted_index.severity | 96 |
| abstract_inverted_index.strongly | 163 |
| abstract_inverted_index.therapy. | 14 |
| abstract_inverted_index.‐dimer | 160 |
| abstract_inverted_index.Mortality | 119 |
| abstract_inverted_index.confirmed | 53 |
| abstract_inverted_index.effective | 12 |
| abstract_inverted_index.episodes, | 86 |
| abstract_inverted_index.highlight | 236 |
| abstract_inverted_index.including | 92 |
| abstract_inverted_index.increased | 6, 167 |
| abstract_inverted_index.mortality | 45, 147, 215 |
| abstract_inverted_index.outcomes. | 262 |
| abstract_inverted_index.patients, | 224 |
| abstract_inverted_index.potential | 23, 238 |
| abstract_inverted_index.reduction | 228 |
| abstract_inverted_index.secondary | 78 |
| abstract_inverted_index.COVID‐19 | 2, 223, 247 |
| abstract_inverted_index.associated | 4, 164, 210 |
| abstract_inverted_index.comparable | 201 |
| abstract_inverted_index.confidence | 129 |
| abstract_inverted_index.critically | 48, 221 |
| abstract_inverted_index.infection. | 55 |
| abstract_inverted_index.management | 244 |
| abstract_inverted_index.mortality, | 76 |
| abstract_inverted_index.mortality. | 170 |
| abstract_inverted_index.reflecting | 225 |
| abstract_inverted_index.responses, | 10 |
| abstract_inverted_index.strategies | 258 |
| abstract_inverted_index.thrombosis | 83, 173 |
| abstract_inverted_index.underscore | 249 |
| abstract_inverted_index.demographic | 93 |
| abstract_inverted_index.transfusion | 88, 198 |
| abstract_inverted_index.alternatives | 24 |
| abstract_inverted_index.inflammatory | 9 |
| abstract_inverted_index.respectively | 153 |
| abstract_inverted_index.standardized | 146 |
| abstract_inverted_index.unvaccinated | 50 |
| abstract_inverted_index.10.0–35.9]; | 141 |
| abstract_inverted_index.36.4–65.7]) | 132 |
| abstract_inverted_index.effectiveness | 36 |
| abstract_inverted_index.necessitating | 11 |
| abstract_inverted_index.observational | 31 |
| abstract_inverted_index.prothrombotic | 7 |
| abstract_inverted_index.retrospective | 30 |
| abstract_inverted_index.significantly | 121, 213 |
| abstract_inverted_index.SARS‐CoV‐2 | 54 |
| abstract_inverted_index.anticoagulants | 17 |
| abstract_inverted_index.anticoagulation | 13, 257 |
| abstract_inverted_index.characteristics, | 91 |
| abstract_inverted_index.low‐molecular‐weight | 26 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5011142198 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 12 |
| corresponding_institution_ids | https://openalex.org/I40034438, https://openalex.org/I4210131693, https://openalex.org/I4210151502, https://openalex.org/I52325 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8899999856948853 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.39645797 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |